Brief: Anthera reports blisibimod BRIGHT-SC IgA nephropathy continues to demonstrate positive trends

Anthera Pharmaceuticals

06/12/2016 21:06

Dec 6 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O :  
    * Anthera reports blisibimod BRIGHT-SC IgA nephropathy 
continues to demonstrate positive trends in week 48 analysis 
    * Anthera Pharmaceuticals -  applications for orphan drug 
and breakthrough status have been filed with FDA, with responses 
expected by late 1Q2017 
 
Source text for Eikon:  ID:nGNXNNJQOa  
Further company coverage:  ANTH.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))